A biotech company tries to retrofit a lung drug for Covid-19 after effects
PureTech Health, a biotech company in Boston, believes it might have a treatment for Covid-19 survivors facing the risk of long-term lung injuries.
Related Articles
Gene therapy trial targeting rare form of deafness shows ‘jaw-droppingly good’ results
Two congenitally deaf children can hear after being treated with a gene therapy, according to new data from an ongoing clinical trial.
In fundamental advance, Google says AlphaFold 3 can map a vast universe of biomolecules
Google on Wednesday unveiled an AI tool capable of predicting the structure and interaction of a vast universe of biomolecules.
2024 STAT Breakthrough Summit West: Medicine’s Future, Now
STAT Breakthrough Summit West is one-day event designed to break down silos across health and medicine by bringing together leaders, entrepreneurs, policymakers, patient advocates —…
Pharma has over $500B in capital for deals
Pharma has over $500B in capital for deals, analysts note — with companies like Novo Nordisk, Eli Lilly, and Merck continuing to be open to…
Pharmalittle: We’re reading about a boy dying in Pfizer trial; AstraZeneca yanking Covid shot, and more
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.
Endo Health ordered to pay more than $1.5 billion in opioid criminal case
Endo “was one of the worst actors in the opioid crisis” said Andrew Kolodny of the Opioid Policy Research Collaborative at Brandeis University.
Why rehabilitation engineers need to listen to patients and their families
“For some reason in rehabilitation research, we’ve kind of lost that ethos” of centering patients, says James Sulzer on a new episode of the “First…
Making the promise of monoclonal antibody therapies available to all
As Americans strive to move beyond Covid-19, it is important to acknowledge that for their 7 million immunocompromised fellow citizens the pandemic continues to be…
Gene therapy trial targeting rare form of deafness shows ‘jaw-droppingly good’ results
Two congenitally deaf children can hear after being treated with a gene therapy, according to new data from an ongoing clinical trial.
Apple pushes into clinical trials with new FDA nod for Apple Watch
The FDA nod means trial sponsors can use Apple Watch’s A-fib history as a secondary endpoint in trials without having to do additional work.